Beyond the Hypothesis of Serum Anticholinergic Activity in Alzheimer's Disease: Acetylcholine Neuronal Activity Modulates Brain-Derived Neurotrophic Factor Production and Inflammation in the Brain

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neurodegenerative Diseases

• Publication date

  2015-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1159/000381531PMID 26138497
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immune dysregulation and cognitive vulnerability in the aging brain: Interactions of microglia, IL-1β, BDNF and synaptic plasticity.

  2015cited by this paper
• Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease

  2014cited by this paper
• Primary cultures of rat cortical microglia treated with nicotine increases in the expression of excitatory amino acid transporter 1 (GLAST) via the activation of the α7 nicotinic acetylcholine receptor.

  2014cited by this paper
• Omega-3 Fatty Acids Enhance Phagocytosis of Alzheimer's Disease-Related Amyloid-β42 by Human Microglia and Decrease Inflammatory Markers

  2013cited by this paper
• The stimulation of dendritic cells by amyloid beta 1-42 reduces BDNF production in Alzheimer's disease patients.

  2013cited by this paper
• Role of Nuclear Receptor on Regulation of BDNF and Neuroinflammation in Hippocampus of β-Amyloid Animal Model of Alzheimer’s Disease

  2013cited by this paper
• Early BDNF Treatment Ameliorates Cell Loss in the Entorhinal Cortex of APP Transgenic Mice

  2013cited by this paper
• The α7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-α release from microglia.

  2012cited by this paper
• Brain-Derived Neurotrophic Factor and Alzheimer’s Disease: Physiopathology and Beyond

  2011cited by this paper
• Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus.

  2011cited by this paper
• Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels.

  2009cited by this paper
• Decreased Serum Brain-Derived Neurotrophic Factor Levels in Elderly Korean with Dementia

  2009cited by this paper
• Neurotrophic factors promote cholinergic differentiation in human embryonic stem cell-derived neurons

  2009cited by this paper
• IC‐P‐027: New metabolic understanding into innovative strategies for early diagnostics and therapy of Alzheimer's disease

  2009cited by this paper
• New insights into brain BDNF function in normal aging and Alzheimer disease.

  2008cited by this paper
• Donepezil, an acetylcholinesterase inhibitor, enhances adult hippocampal neurogenesis.

  2008cited by this paper
• Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar β amyloid peptide (1-42)-stimulated microglia

  2008cited by this paper
• Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer’s disease

  2008cited by this paper
• Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories

  2007cited by this paper
• Pharmacological evidence of cholinergic involvement in adult hippocampal neurogenesis in rats.

  2006cited by this paper
• Alzheimer's disease drugs promote neurogenesis.

  2006cited by this paper
• Microglial α7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role

  2006cited by this paper
• Effects of huperzine A on memory deficits and neurotrophic factors production after transient cerebral ischemia and reperfusion in mice.

  2006cited by this paper
• Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's disease

  2005cited by this paper
• Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease

  2004cited by this paper
• Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.

  2003cited by this paper
• Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction.

  2003cited by this paper
• Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease.

  2003cited by this paper
• Tumor Necrosis Factor Inhibits Neurite Outgrowth and Branching of Hippocampal Neurons by a Rho-Dependent Mechanism

  2002cited by this paper
• A new brain‐derived neurotrophic factor transcript and decrease inbrain‐derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex

  2002cited by this paper
• Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment

  2002cited by this paper
• Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease.

  2000cited by this paper
• Brain‐derived neurotrophic factor and neurotrophin‐3 levels in Alzheimer's disease brains

  2000cited by this paper
• Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas.

  2000cited by this paper
• Alterations in Trk A, Trk B and Trk C Receptor Immunoreactivities in Parietal Cortex and Cerebellum in Alzheimer’s Disease

  2000cited by this paper
• BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies.

  1999cited by this paper
• Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease.

  1999cited by this paper
• Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease

  1999cited by this paper
• Nerve growth factor and brain‐derived neurotrophic factor increase neurotransmitter release in the rat visual cortex

  1998cited by this paper
• Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease.

  1998cited by this paper
• Cholinergic strategies for Alzheimer’s disease

  1998cited by this paper
• Brain-derived neurotrophic factor is reduced in Alzheimer's disease.

  1997cited by this paper
• Neurotrophic factors in memory disorders.

  1994cited by this paper
• Cholinergic regulation of hippocampal brain-derived neurotrophic factor mRNA expression: evidence from lesion and chronic cholinergic drug treatment studies.

  1993cited by this paper
• BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease.

  1991cited by this paper
• Purification of a new neurotrophic factor from mammalian brain.

  1982cited by this paper

• Dihuang Yinzi Improves Scopolamine-Induced Learning and Memory Impairment by Regulating Plasma Exosome-Derived BDNF.

  2025cites this paper
• Metal-Associated Particulate Matter (PM2.5) Induces Cognitive Dysfunction: Polygonum multiflorum Improves Neuroinflammation and Synaptic Function

  2025influential citation
• Discovery of rhynchophylline and mitraphylline in two Thai Mitragyna species and the investigation of their biological activity via opioid gene expression analysis

  2025influential citation
• Navigating the Labyrinth: Understanding Dementia’s Effect on the Brain and the Role of Educational Therapy-Based Interventions in Dementia Treatment

  2024cites this paper
• The effect of acetylcholinesterase inhibitor rivastigmine in pentylenetetrazole-induced kindling model of epilepsy in rats

  2024cites this paper
• Integrated metabolome and microbiome strategy reveals the therapeutic effect of nervonic acid on Alzheimer's disease rats.

  2024cites this paper
• BDNF Signaling in Vascular Dementia and Its Effects on Cerebrovascular Dysfunction, Synaptic Plasticity, and Cholinergic System Abnormality

  2024cites this paper
• The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons.

  2024cites this paper
• Ethanol extract of Evodia lepta Merr. ameliorates cognitive impairment through inhibiting NLRP3 inflammasome in scopolamine-treated mice

  2024cites this paper
• Many Paths to Alzheimer’s Disease: A Unifying Hypothesis Integrating Biological, Chemical, and Physical Risk Factors

  2023cites this paper
• The Neurobiology and Therapeutic Potential of Multi-Targeting β-secretase, Glycogen Synthase Kinase 3β and Acetylcholinesterase in Alzheimer's Disease.

  2023cites this paper
• Effects of baicalein with memantine on aluminium chloride-induced neurotoxicity in Wistar rats

  2023cites this paper
• High inhibition efficacy of pancreatic cholesterol esterase and porcine pancreatic lipase from natural products

  2023cites this paper
• Screening of phytochemicals, toxicities, and activities of three Dillenia species

  2022cites this paper
• Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease

  2022cites this paper
• The Methylglyoxal/RAGE/NOX-2 Pathway is Persistently Activated in the Hippocampus of Rats with STZ-Induced Sporadic Alzheimer’s Disease

  2022cites this paper
• The Aqueous Extract of Humulus japonicus Ameliorates Cognitive Dysfunction in Alzheimer's Disease Models via Modulating the Cholinergic System

  2022cites this paper
• The Effect of Choline Alphoscerate on Non spatial memory and Neuronal Differentiation in a Rat Model of Dual Stress.

  2022cites this paper
• Evaluation of neuroprotective agents acting via the BDNF–TrkB pathway using AI‐enabled predictions of ligand–receptor interactions

  2022cites this paper
• Synthesis of 1-hydroxy-3-O-substituted xanthone derivatives and their structure-activity relationship on acetylcholinesterase inhibitory effect

  2021cites this paper
• Formulations for effective detoxification derived fromthree medicinalplants: Thunbergia laurifolia,Clerodendrum disparifoliumand Rotheca serrata.

  2021cites this paper
• Aluminum Microcomb Electrodes on Silicon Wafer for Detecting Val66Met Polymorphism in Brain-Derived Neurotrophic Factor

  2021cites this paper
• Anti-inflammatory and detoxification activities of some Ipomoea species determined by ion channel inhibition and their phytochemical constituents

  2021cites this paper
• Efficiency Evaluation and Usages of Thunbergia alata, Thunbergia erecta and their Combination

  2021cites this paper
• Attenuative Effects of Fluoxetine and Triticum aestivum against Aluminum-Induced Alzheimer’s Disease in Rats: The Possible Consequences on Hepatotoxicity and Nephrotoxicity

  2021cites this paper
• Synergic treatment of Alzheimer’s disease with brain targeted nanoparticles incorporating NgR-siRNA and brain derived neurotrophic factor

  2020cites this paper
• Alterations of GABA B receptors in the APP/PS1 mouse model of Alzheimer's disease.

  2020cites this paper
• Oleamide in Ipomoea and Dillenia species and inflammatory activity investigated through ion channel inhibition.

  2020cites this paper
• QTC-4-MeOBnE rescues scopolamine-induced memory deficits in mice by targeting oxidative stress, neuronal plasticity and apoptosis.

  2020cites this paper
• Is Blood Brain-Derived Neurotrophic Factor a Useful Biomarker to Monitor Mild Cognitive Impairment Patients?

  2020cites this paper
• Effect of doxycycline and meloxicam on cytokines, brain-derived neurotrophic factor, matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-3 and cyclooxygenase-2 in brain

  2020cites this paper
• The Effect of Choline Alphoscerate on Non spatial memory and Neurogenesis in a Rat Model of Dual Stress

  2020cites this paper
• Cross-talk between guanidinoacetate neurotoxicity, memory and possible neuroprotective role of creatine.

  2019cites this paper
• Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer’s Disease: Are There Methodological Biases?

  2018cites this paper
• Neurotrophins and cholinergic enzyme regulated by calpain-2: New insights into neuronal apoptosis induced by polybrominated diphenyl ether-153.

  2018cites this paper
• Co-Administration of TiO2 Nanowired Mesenchymal Stem Cells with Cerebrolysin Potentiates Neprilysin Level and Reduces Brain Pathology in Alzheimer’s Disease

  2017cites this paper
• Interdisciplinary researches for potential developments of drugs and natural products

  2017cites this paper
• Screening of phytochemicals and toxicity of medicinal plants, Dillenia species, reveals potential natural product resources

  2017cites this paper
• The cholinergic anti‐inflammatory pathway: An innovative treatment strategy for neurological diseases

  2017cites this paper
• Clinical and Environmental Correlates of Serum BDNF: A Descriptive Study with Plausible Implications for AD Research.

  2017cites this paper
• Xanthoceras sorbifolia extracts ameliorate dendritic spine deficiency and cognitive decline via upregulation of BDNF expression in a rat model of Alzheimer's disease.

  2016cites this paper
• Significance of Serum Anticholinergic Activity Index in Alzheimer's Disease

  2015cites this paper